Table 1 Dialysis patient characteristics who were offered frailty assessment by assessment completion (n = 58)
Characteristics | Did not complete or refuse frailty assessment (n = 13) | Completed frailty assessment (n = 45) | p-value | Total |
|---|---|---|---|---|
Dialysis shift, early morning shift | 7 (53.8%) | 23 (51.1%) | p = 0.862 | 30 (51.7%) |
 Mid-morning shift | 6 (46.2%) | 22 (48.9%) |  | 28 (48.3%) |
Testing day, MWF | 6 (46.2%) | 24 (53.3%) | p = 0.648 | 30 (51.7%) |
 TTS | 7 (53.8%) | 21 (46.7%) |  | 28 (48.3%) |
Age, mean (s.d.) | 68.2 (7.0) | 69.9 (10.2) | p = 0.5850 | 69.5 (9.5) |
Gender, Male | 13 (100%) | 44 (97.8%) | p = 1.000 | 57 (98.3%) |
Race/ethnicity, NH white | 4 (30.8%) | 18 (40.0%) | p = 0.845 | 22 (37.9%) |
 NH black | 8 (61.5%) | 22 (48.9%) |  | 30 (51.7%) |
 NH Asian | 0 | 1 (2.2%) |  | 1 (1.7%) |
 Hispanic | 1 (7.7%) | 4 (8.9%) |  | 5 (8.6%) |
BMI, mean (s.d.) | 30.1 (9.4) | 29.1 (7.0) | p = 0.6657 | 29.3 (7.0) |
Diabetes | 11 (84.6%) | 34 (75.6%) | p = 0.711 | 45 (77.6%) |
Hypertension | 12 (92.3%) | 39 (86.7%) | p = 1.000 | 51 (87.9%) |
Cerebrovascular accident (CVA) | 2 (15.4%) | 5 (11.1%) | p = 0.648 | 7 (12.1%) |
Obstructive sleep apnea (OSA) | 5 (38.5%) | 17 (37.8%) | p = 1.000 | 22 (37.9%) |
Obesity | 6 (46.1%) | 14 (31.1%) | p = 0.339 | 20 (34.5%) |
Peripheral vascular disease (PVD) | 8 (61.5%) | 6 (13.3%) | p = 0.001 | 14 (24.1%) |
Congestive heart failure or coronary artery disease | 8 (61.5%) | 19 (42.2%) | p = 0.219 | 27 (46.5%) |
Vascular access, catheter | 3 (23.1%) | 5 (11.1%) | p = 0.385 | 8 (13.8%) |
 Arteriovenous graft | 4 (30.8%) | 10 (22.2%) |  | 14 (24.1%) |
 Arteriovenous fistula | 6 (46.2%) | 30 (66.7%) |  | 36 (62.1%) |
Access failure, yes | 5 (38.5%) | 16 (35.6%) | p = 1.000 | 21 (36.2%) |
Dialysis vintage, mean (s.d.) | 5.9 (3.3) | 4.1 (3.2) | p = 0.07 | 4.5 (3.3) |
KT waitlist status, not a candidate | 13 (100%) | 23 (53.5%) | p = 0.005 | 36 (64.3%) |
 Work up in progress | 0 | 17 (39.5%) |  | 17 (30.4%) |
 Listed | 0 | 3 (7.0%) |  | 3 (5.4%) |
Urea Reduction Ratio (> 67%), mean (s.d.) | 73.2% (4.4) | 74.0% (4.5) | p = 0.55 | 73.8% (4.5) |
KT/V ( > = 1.2), mean (s.d.) | 1.5 (0.2) | 1.5 (0.2) | p = 0.8091 | 1.5 (0.2) |
Potassium (3.5–4.7 mmol/L), mean (s.d.) | 4.5 (0.6) | 4.3 (0.5) | p = 0.3205 | 4.3 (0.5) |
Sodium (135–145 mmol/L), mean (s.d.) | 128.4 (27.3) | 136.8 (2.8) | p = 0.0422 | 134.9 (13.2) |
Phosphorous (3.5–5.5 XX), mean (s.d.) | 4.9 (1.3) | 4.6 (1.0) | p = 0.3416 | 4.7 (1.0) |
PTH (< 600 pg/mL), mean (s.d.) | 902.1 (1139.0) | 640.0 (398.2) | p = 0.1948 | 698.7 (638.5) |
Calcium (8.5–10.3 mg/dL), mean (s.d.) | 8.7 (0.8) | 8.8 (0.5) | p = 0.5458 | 58 (0.6) |
Albumin (3.5–4.2 g/dL), mean (s.d.) | 3.4 (0.8) | 3.8 (0.6) | p = 0.0187 | 3.7 (0.7) |
Hemoglobin (9–11 g/dl), mean (s.d.) | 10.2 (1.0) | 10.3 (1.2) | p = 0.8005 | 10.3 (1.1) |
Charlson comorbidity index, median (IQR) | 8 (7–9) | 7 (5–8) | p = 0.2216 | 7.3 (6–9) |
Estimated 10 years survival, 0% | 11 (84.6%) | 30 (66.7%) | p = 0.106 | 41 (70.7%) |
 2% | 2 (15.4%) | 2 (4.4%) |  | 4 (6.9%) |
 21% | 0 | 11 (24.4%) |  | 11 (19.0%) |
 53% | 0 | 2 (4.4%) |  | 2 (3.4%) |
Pill count, mean (s.d.) | 18.3 (10.2) | 19.3 (8.9%) | p = 0.7898 | 19.1 (9.1) |
Life sustaining treatment, None | 1 (7.7%) | 12 (26.7%) | p = 0.407 | 13 (22.4%) |
 DNR and/or DNI | 3 (23.1%) | 7 (15.6%) |  | 10 (17.2%) |
 Full code | 9 (69.2%) | 26 (57.8%) |  | 35 (60.3%) |
ACE or ARB, yes | 1 (7.7%) | 5 (11.1%) | p = 0.594 | 6 (10.3%) |
CCB, yes | 7 (53.8%) | 15 (33.3%) | p = 0.208 | 22 (37.9%) |
Beta blockers, yes | 9 (69.2%) | 22 48.9%) | P = 0.195 | 31 (53.4%) |
Diuretics, yes | 1 (7.7%) | 13 (28.9%) | P = 0.155 | 14 (24.1%) |
Alpha blockers, yes | 0 | 5 (11.1%) | p = 0.267 | 5 (8.6%) |
Alpha-2 agonists, yes | 0 | 1 (2.2%) | p = 1.000 | 1 (1.72%) |
Vasodilators, yes | 7 (53.8%) | 9 (20.0%) | p = 0.031 | 16 (27.6%) |
Midodrine for hypotension during dialysis, yes | 3 (23.1%) | 12 (26.7%) | p = 1.000 | 15 (25.9%) |
ESA for anemia management, yes | 11 (84.6%) | 35 (77.8%) | p = 0.716 | 46 (79.3%) |
Phosphate binders, yes | 9 (69.2%) | 28 (62.2%) | p = 0.751 | 37 (63.8%) |